Abstract
Purpose
To examine the impact of a new model of care, in which a clinical pharmacist conducts structured medication reviews and a multi-professional team collates systematic medication care plans, on the number of unidentified DRPs in a hospital setting.
Methods
In a prospective two-period study, patients admitted to an internal medicine ward at the University Hospital of Lund, Sweden, were included if they were ≥ 65 years old, used ≥ 3 medications on a regular basis and had stayed on the ward for ≥ 5 weekdays. Intervention patients were given the new model of care and control patients received conventional care. DRPs were then retrospectively identified after study completion from blinded patient records for both intervention and control patients. Two pairs of evaluators independently evaluated and classified these DRPs as having been identified/unidentified during the hospital stay and according to type and clinical significance. The primary endpoint was the number of unidentified DRPs, and the secondary endpoints were the numbers of unidentified DRPs within each type and clinical significance category.
Results
The study included a total of 141 (70 intervention and 71 control) patients. The intervention group benefited from a reduction in the total number of unidentified DRPs per patient during the hospital stay: intervention group median 1 (1st–3rd quartile 0–2), control group 9 (6–13.5) (p < 0.001), and also in the number of medications associated with unidentified DRPs per patient: intervention group 1 (0–2), control group 8 (5–10) (p < 0.001). All sub-categories of DRPs that were frequent in the control group were significantly reduced in the intervention group. Similarly, the DRPs were less clinically significant in the intervention group.
Conclusions
A multi-professional team, including a clinical pharmacist, conducting structured medication reviews and collating systematic medication care plans proved very effective in reducing the number of unidentified DRPs for elderly in-patients.
Similar content being viewed by others
References
Strand LM, Morley PC, Cipolle RJ et al (1990) Drug-related problems: their structure and function. DICP 24(11):1093–1097
Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27(7–8):832–840
Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta- analysis of prospective studies. JAMA 279(15):1200–1205
Beijer HJ, de Blaey CJ (2002) Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 24(2):46–54
Col N, Fanale JE, Kronholm P (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150(4):841–845
Bero LA, Lipton HL, Bird JA (1991) Characterization of geriatric drug-related hospital readmissions. Med Care 29(10):989–1003
Azaz-Livshits T, Levy M, Sadan B et al (1998) Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol 45(3):309–314
Bates DW, Spell N, Cullen DJ et al (1997) The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA 277(4):307–311
Classen DC, Pestotnik SL, Evans RS et al (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277(4):301–306
Winterstein AG, Sauer BC, Hepler CD et al (2002) Preventable drug-related hospital admissions. Ann Pharmacother 36(7–8):1238–1248
European Society of Clinical Pharmacy What is clinical pharmacy? In: wwwescpweborg/site/cms/contentViewArticleasp?article = 1712ed.
Lipton HL, Bero LA, Bird JA et al (1992) The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing. A randomized controlled trial. Med Care 30(7):646–658
Bjornson DC, Hiner WO Jr, Potyk RP et al (1993) Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 50(9):1875–1884
Rich MW, Beckham V, Wittenberg C et al (1995) A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333(18):1190–1195
Scullin C, Scott MG, Hogg A et al (2007) An innovative approach to integrated medicines management. J Eval Clin Pract 13(5):781–788
Boyko WL Jr, Yurkowski PJ, Ivey MF et al (1997) Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 54(14):1591–1595
McMullin ST, Hennenfent JA, Ritchie DJ et al (1999) A prospective, randomized trial to assess the cost impact of pharmacist- initiated interventions. Arch Intern Med 159(19):2306–2309
Lannigan NA (1994) Screening for pharmaceutical care issues on a general surgical unit. Pharm J 252:134–135
Gillespie U, Alassaad A, Henrohn D et al (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older a randomized controlled trial. Arch Intern Med 169(9):894–900
The National Board of Health and Welfare (2003) [Indikatorer för utvärdering av kvaliteten i äldres läkemedelsterapi- Socialstyrelsens förslag]. Stockholm
Cipolle RJ, Strand LM, Morley PC (1998) Pharmaceutical care parctice. The McGraw-Hill Companies Inc, New York
Hatoum HT, Hutchinson RA, Witte KW et al (1988) Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm 22(3):252–259
Blix HS, Viktil KK, Reikvam A et al (2004) The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 60(9):651–658
Blix HS, Viktil KK, Moger TA et al (2006) Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci 28(3):152–158
Mannheimer B, Ulfvarson J, Eklof S et al (2006) Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol 62(12):1075–1081
Barber ND, Batty R, Ridout DA (1997) Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm 54(4):397–405
Lee J, McPherson ML (2006) Outcomes of recommendations by hospice pharmacists. Am J Health Syst Pharm 63(22):2235–2239
Bosma L, Jansman FG, Franken AM et al (2008) Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci 30(1):31–38
van Mil JW, Westerlund LO, Hersberger KE et al (2004) Drug-related problem classification systems. Ann Pharmacother 38(5):859–867
Donabedian A (2003) An introduction to quality assurance in health care. Oxford University Press, Inc., New York
Wilson S, Ruscoe W, Chapman M et al (2001) General practitioner-hospital communications: a review of discharge summaries. J Qual Clin Pract 21(4):104–108
Gleason KM, Groszek JM, Sullivan C et al (2004) Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am J Health Syst Pharm 61(16):1689–1695
Midlov P, Bergkvist A, Bondesson A et al (2005) Medication errors when transferring elderly patients between primary health care and hospital care. Pharm World Sci 27(2):116–120
Bondesson A, Hellstrom L, Eriksson T et al (2009) A structured questionnaire to assess patient compliance and beliefs about medicines taking into account the ordered categorical structure of data. J Eval Clin Pract 15(4):713–723. doi:10.1111/j.1365-2753.2008.01088.x
Midlov P, Holmdahl L, Eriksson T et al (2008) Medication report reduces number of medication errors when elderly patients are discharged from hospital. Pharm World Sci 30(1):92–98
Midlov P, Deierborg E, Holmdahl L et al (2008) Clinical outcomes from the use of medication report when elderly patients are discharged from hospital. Pharm World Sci 30(6):840–845. doi:10.1007/s11096-008-9236-1
Bergkvist A, Midlov P, Hoglund P et al (2009) Improved quality in the hospital discharge summary reduces medication errors-LIMM: Landskrona Integrated Medicines Management. Eur J Clin Pharmacol 65(10):1037–1046. doi:10.1007/s00228-009-0680-1
Bergkvist A, Midlov P, Hoglund P et al (2009) A multi-intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM-Landskrona Integrated Medicines Management. J Eval Clin Pract 15(4):660–667. doi:10.1111/j.1365-2753.2008.01080.x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bondesson, Å., Eriksson, T., Kragh, A. et al. In-hospital medication reviews reduce unidentified drug-related problems. Eur J Clin Pharmacol 69, 647–655 (2013). https://doi.org/10.1007/s00228-012-1368-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-012-1368-5